Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
04/2012
04/18/2012EP2440213A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals.
04/18/2012EP2440207A1 Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
04/18/2012EP2440194A1 Methods and compositions for the induction of hypothermia
04/18/2012EP1910844B1 Cross-beta structure binding compounds
04/18/2012EP1598346B1 Process for producing acid adduct salt of polyacidic base compound
04/18/2012EP1409467B1 A n-acylsphingosine glucosyltransferase inhibitor
04/18/2012EP1284724B1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/18/2012EP1207876B9 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing
04/18/2012EP1005488B9 Receptor that binds trail
04/18/2012EP0618925B2 Antisense oligonucleotides
04/18/2012CN1813699B Medicinal composition
04/18/2012CN102421761A 二氨基杂环甲酰胺化合物 Diamino heterocyclic carboxamide compound
04/18/2012CN102421450A 治疗虚弱的方法 Method of treating weak
04/18/2012CN102421429A Selective ep4 receptor agonistic substance for treatment of cancer
04/18/2012CN102417483A 作为parp抑制剂的2-苯基-1h-苯并咪唑-4-甲酸酯衍生物 As parp inhibitors -1h- benzimidazole-2-phenyl-4-ester derivative
04/18/2012CN102417480A Spirocyclic nitriles as protease inhibitors
04/18/2012CN102416173A 预防与猪环状病毒-2相关的心肌炎、流产和宫内感染 Prevention and porcine circovirus -2 associated myocarditis, abortion and intrauterine infection
04/18/2012CN102416116A Chinese medicinal preparation for treating vocal nodules quickly
04/18/2012CN102133334B 一种复方楮实子制剂的制备方法及其用途 A COMPOUND Fructus formulation preparation and use
04/18/2012CN101601702B 抗老化剂 Anti-aging agents
04/18/2012CN101511348B 含有包封他汀类之纳米颗粒的药物组合物 He containing encapsulated particles of nanometer statin pharmaceutical compositions
04/18/2012CN101489566B Aha基因的RNAi调控及其治疗性应用 RNAi Regulation and therapeutic applications Aha gene
04/18/2012CN101489562B 用于治疗脊髓增生病的jak抑制剂 For the treatment of spinal cord Hyperplasia jak inhibitor
04/18/2012CN101360507B Method of using guava extract and composition including guava extract
04/17/2012US8160821 Method for supporting a diagnosis of an effect of a treatment by using anthracycline anticancer drugs and a device for supporting a diagnosis for an effect of a treatment by using anthracycline anticancer drugs
04/17/2012US8158750 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
04/17/2012US8158669 Method for treating neovascularization
04/17/2012US8158617 Fused heterocyclic compound and use thereof
04/17/2012US8158604 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
04/17/2012US8158592 for treatment of atopic conditions (dermatitis, allergies); point mutations; immunotherapy
04/17/2012US8158385 Cell death-inducing agent
04/17/2012US8158171 Methods of lowering blood cholesterol via oral fenugreek seed extract compositions
04/17/2012US8158156 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
04/17/2012CA2599328C Quinazoline derivative having tyrosine kinase inhibitory activity
04/17/2012CA2585705C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
04/17/2012CA2511595C Optically active dihydropyridine derivative
04/17/2012CA2493843C Azolidinone-vinyl fused-benzene derivatives
04/17/2012CA2488120C Pharmaceutical composition for improving cerebral function and method for improving cerebral function
04/17/2012CA2474104C N-oxides of n-phenyl-2-pyrimidine-amine derivatives
04/17/2012CA2469138C Inhibitors of cytosolic phospholipase a2
04/17/2012CA2468948C Preventives or remedies for alzheimer's disease or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
04/17/2012CA2427844C Naphthalene derivatives
04/17/2012CA2407806C Use of heparin or nonanticoagulant heparin for inhibiting apoptosis arising from ischemia perfusion injury
04/17/2012CA2402894C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method
04/17/2012CA2377607C Neurotrophic factor receptor
04/17/2012CA2363958C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
04/17/2012CA2360664C Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
04/17/2012CA2145778C Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
04/12/2012WO2012046869A1 Cyclic amide derivative
04/12/2012WO2012046792A1 Gpr119 agonist
04/12/2012WO2012046771A1 Cycloalkane compound
04/12/2012WO2012046681A1 Agent for inhibiting expression of lipid metabolism related mrna
04/12/2012WO2012046653A1 Amine compound and use for same
04/12/2012WO2012045285A1 Pharmaceutical composition and application thereof
04/12/2012WO2012045282A1 Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction
04/12/2012WO2012045118A1 Combination therapy for the treatment of depression and other non-infectious diseases
04/12/2012US20120090042 Polypeptides Having Phytase Activity And Polynucleotides Encoding Same
04/12/2012US20120088796 Compounds that inhibit (block) bitter taste in composition and use thereof
04/12/2012US20120088783 Chroman derivatives
04/12/2012US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
04/12/2012US20120088777 5-ht1a receptor subtype agonist
04/12/2012US20120088754 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120088737 Novel acyl guanidine derivatives
04/12/2012US20120087979 Extended-release oral dosage forms for poorly soluble amine drugs
04/12/2012US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
04/12/2012CA2816595A1 Combination therapy for the treatment of depression and other non-infectious diseases
04/12/2012CA2813639A1 Cyclic amide derivative
04/11/2012EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier
04/11/2012EP2438927A1 Pharmaceutical composition, food or beverage, and methods for these products
04/11/2012EP2438917A1 Transdermal preparation
04/11/2012EP2438916A1 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
04/11/2012EP2438913A1 A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling
04/11/2012EP1724258B1 Heteroarylphenylurea derivative
04/11/2012EP1650191B1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same
04/11/2012EP1503794B1 Methods of treatement using ctla-4 antibodies
04/11/2012EP1362030B1 Novel benzoylguanidine salt
04/11/2012EP1341909B2 A method for in vitro molecular evolution of protein function
04/11/2012EP1326840B1 Substituted heterocyclic compounds for treating multidrug resistance
04/11/2012EP1261590B1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
04/11/2012EP1235912B1 Tumour-specific vector for gene therapy
04/11/2012EP1125947B1 Human H37 protein and cDNA encoding the same
04/11/2012CN102414209A 运动障碍治疗剂 Dyskinesia therapeutic agent
04/11/2012CN102414201A Novel solvate crystals
04/11/2012CN102414200A 奥美沙坦酯的制备方法 Preparation of olmesartan medoxomil
04/11/2012CN102413841A 鱼类寄生虫驱除方法 Fish antiparasitic method
04/11/2012CN102413840A Agent for regulating composition ratio of intestinal bacterial flora
04/11/2012CN102413823A 以羧酰胺衍生物和/或其盐为活性成分的scca-1产生抑制剂 To carboxamide derivatives and / or salts thereof as an active ingredient scca-1 production inhibitor
04/11/2012CN102413822A 提高哺乳动物中内源性缩醛磷脂水平的方法 Improved mammalian endogenous level of a plasmalogen
04/11/2012CN102408470A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation
04/11/2012CN102406894A 一种治疗经前紧张综合症的中药 A premenstrual tension syndrome of traditional Chinese medicine
04/11/2012CN102406889A 一种治疗自汗、盗汗、多汗的穴位贴膏 A method of treating spontaneous, night sweats, sweating the points Plaster
04/11/2012CN102406830A Room-temperature preparation method for submicron powder Qingshu powder and special bidirectional airflow screening machine
04/11/2012CN102406707A Normal-temperature preparation method of ultramicro Scutellaria baicalensis powder and special bidirectional airflow screening machine thereof
04/11/2012CN102406641A 索拉非尼在治疗纤维化病中的应用 Sorafenib in the treatment of fibrotic disease
04/11/2012CN101926974B 治疗中老年人流口水中药组合物 Chinese medicine treatment in the elderly drooling composition
04/11/2012CN101700229B 静脉注射用前列地尔长循环脂微球制剂及其制备方法 Intravenous injection of alprostadil long cycle Lipo and its preparation method
04/11/2012CN101466687B Activating agent for peroxisome proliferator activated receptor delta
04/11/2012CN101309932B 新粘蛋白型糖蛋白及其应用 New mucin-type glycoprotein and its applications
04/10/2012US8153696 Medicinal preparation particularly for the treatment of slipped discs hernias
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 1564